Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311747504> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4311747504 abstract "Abstract Background COVID-19 disease severity and outcomes have been linked to high antibody titers and a dysregulated neutrophil immune response. Here we query associations and connections between the endogenous SARS-CoV-2 antibody response and neutrophil activation in COVID-19. Methods Baseline serum or plasma samples from 57 patients hospitalized on oxygen with COVID-19 were used to perform; 1) quantitative measurements of SARS-CoV-2 specific antibodies using a luciferase-based immunoprecipitation system assay, 2) quantitative measurements of neutrophil specific biomarkers using Luminex technology, and 3) neutrophil extracellular traps (NETs) as measured by myeloperoxidase-DNA (MPO-DNA) complexes by ELISA. Absolute neutrophil count (ANC) and immature granulocyte count (IGC) were measured from complete blood counts (CBC). Antibody levels were compared by disease severity using Wilcoxon rank-sum test and correlations were generated between antibody levels and neutrophil activation markers using Spearman’s correlation (SC). Results In a cohort of hospitalized patients, severe/critical COVID-19 was associated with higher levels of nucleocapsid-IgA (p=0.011) as well as spike-IgG (p= 0.0007) compared to moderate disease, while spike-IgA and nucleocapsid-IgG showed similar associations, trending towards significance (Figure 1A). Levels of IgG-spike and IgG-nucleocapsid both had significant correlations with the ANC (SC 0.33, p = 0.029; SC 0.38 p = 0.012). All four antibody titers showed strong correlations with IGC, lactoferrin and lipocalin-2, evidence of emergency granulopoiesis. Further, S100A9, a component calprotectin correlated with spike-IgG and nucleocapsid-IgA levels (SC 0.29, p = 0.030, SC 0.29 p = 0.029). Lastly, we found circulating NETs correlated with spike IgA levels (SC 0.38 p = 0.006), and its correlations with IgG-spike and IgA-nucleocapsid additionally approached significance with NETs levels as well (Figure 1B). Antibody Levels Correlate with Disease Severity and Neutrophil Activation Markers Figure 1: A) Levels of anti-Spike and anti-Nucleocapsid IgA and IgG levels measured in the serum of 57 unvaccinated hospitalized COVID-19 patients. Moderate illness represents ordinal scale 5 requiring low flow oxygen, while severe/critical patients represent ordinal scale 6 and 7, requiring high flow oxygen, non-invasive or mechanical ventilation, respectively. P values are compared by a Wilcoxon ranked sum test. B) Heatmap showing Spearman correlations between levels of anti-Spike and anti-Nucleocapsid IgA and IgG and markers of neutrophil activation. P values for individual correlations are represented in parentheses. MPO (myeloperoxidase), ANC (absolute neutrophil count), S100A9 (S100 calcium binding protein A9). Conclusion Higher anti-spike and anti-nucleocapsid IgG and IgA levels associate with more severe COVID-19 illness. Further, endogenous SARS-CoV-2 specific antibody levels associate with markers of emergency granulopoiesis and neutrophil activation. Inhibiting antibody mediated neutrophil activation may improve outcomes in COVID-19. Disclosures All Authors: No reported disclosures." @default.
- W4311747504 created "2022-12-28" @default.
- W4311747504 creator A5020215482 @default.
- W4311747504 creator A5024634769 @default.
- W4311747504 creator A5025157938 @default.
- W4311747504 creator A5031834136 @default.
- W4311747504 creator A5040108934 @default.
- W4311747504 creator A5041450311 @default.
- W4311747504 creator A5052485494 @default.
- W4311747504 creator A5062640421 @default.
- W4311747504 creator A5064158691 @default.
- W4311747504 creator A5070292544 @default.
- W4311747504 creator A5070481231 @default.
- W4311747504 creator A5076074380 @default.
- W4311747504 creator A5087705062 @default.
- W4311747504 date "2022-12-01" @default.
- W4311747504 modified "2023-10-18" @default.
- W4311747504 title "1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation" @default.
- W4311747504 doi "https://doi.org/10.1093/ofid/ofac492.913" @default.
- W4311747504 hasPublicationYear "2022" @default.
- W4311747504 type Work @default.
- W4311747504 citedByCount "0" @default.
- W4311747504 crossrefType "journal-article" @default.
- W4311747504 hasAuthorship W4311747504A5020215482 @default.
- W4311747504 hasAuthorship W4311747504A5024634769 @default.
- W4311747504 hasAuthorship W4311747504A5025157938 @default.
- W4311747504 hasAuthorship W4311747504A5031834136 @default.
- W4311747504 hasAuthorship W4311747504A5040108934 @default.
- W4311747504 hasAuthorship W4311747504A5041450311 @default.
- W4311747504 hasAuthorship W4311747504A5052485494 @default.
- W4311747504 hasAuthorship W4311747504A5062640421 @default.
- W4311747504 hasAuthorship W4311747504A5064158691 @default.
- W4311747504 hasAuthorship W4311747504A5070292544 @default.
- W4311747504 hasAuthorship W4311747504A5070481231 @default.
- W4311747504 hasAuthorship W4311747504A5076074380 @default.
- W4311747504 hasAuthorship W4311747504A5087705062 @default.
- W4311747504 hasBestOaLocation W43117475041 @default.
- W4311747504 hasConcept C126322002 @default.
- W4311747504 hasConcept C134897094 @default.
- W4311747504 hasConcept C159047783 @default.
- W4311747504 hasConcept C159654299 @default.
- W4311747504 hasConcept C164585084 @default.
- W4311747504 hasConcept C203014093 @default.
- W4311747504 hasConcept C22889606 @default.
- W4311747504 hasConcept C2776914184 @default.
- W4311747504 hasConcept C2777063308 @default.
- W4311747504 hasConcept C2780898057 @default.
- W4311747504 hasConcept C29730261 @default.
- W4311747504 hasConcept C32611913 @default.
- W4311747504 hasConcept C71924100 @default.
- W4311747504 hasConcept C74133956 @default.
- W4311747504 hasConceptScore W4311747504C126322002 @default.
- W4311747504 hasConceptScore W4311747504C134897094 @default.
- W4311747504 hasConceptScore W4311747504C159047783 @default.
- W4311747504 hasConceptScore W4311747504C159654299 @default.
- W4311747504 hasConceptScore W4311747504C164585084 @default.
- W4311747504 hasConceptScore W4311747504C203014093 @default.
- W4311747504 hasConceptScore W4311747504C22889606 @default.
- W4311747504 hasConceptScore W4311747504C2776914184 @default.
- W4311747504 hasConceptScore W4311747504C2777063308 @default.
- W4311747504 hasConceptScore W4311747504C2780898057 @default.
- W4311747504 hasConceptScore W4311747504C29730261 @default.
- W4311747504 hasConceptScore W4311747504C32611913 @default.
- W4311747504 hasConceptScore W4311747504C71924100 @default.
- W4311747504 hasConceptScore W4311747504C74133956 @default.
- W4311747504 hasIssue "Supplement_2" @default.
- W4311747504 hasLocation W43117475041 @default.
- W4311747504 hasLocation W43117475042 @default.
- W4311747504 hasOpenAccess W4311747504 @default.
- W4311747504 hasPrimaryLocation W43117475041 @default.
- W4311747504 hasRelatedWork W1522276746 @default.
- W4311747504 hasRelatedWork W1764075393 @default.
- W4311747504 hasRelatedWork W1779694311 @default.
- W4311747504 hasRelatedWork W1953252249 @default.
- W4311747504 hasRelatedWork W1984647379 @default.
- W4311747504 hasRelatedWork W2057266757 @default.
- W4311747504 hasRelatedWork W2079937358 @default.
- W4311747504 hasRelatedWork W2365431450 @default.
- W4311747504 hasRelatedWork W2393317881 @default.
- W4311747504 hasRelatedWork W2414181163 @default.
- W4311747504 hasVolume "9" @default.
- W4311747504 isParatext "false" @default.
- W4311747504 isRetracted "false" @default.
- W4311747504 workType "article" @default.